Liang Chen

Liang (Kevin) Chen is a seasoned professional in the biotechnology and pharmaceutical sectors, currently serving as Lead and Director of Business Development at I-Mab Biopharma and Director of Business Development at ABio-X. As a Co-Founder of Ensem Therapeutics, Chen has played a pivotal role in preclinical R&D strategy, securing significant licensing deals and financing. Previous roles include Vice President, Assistant Vice President, and Associate at CBC Group, where strategic oversight on private equity investments was provided, and contributions to early clinical development at Everest Medicines. Chen has held product management positions at Roche and Pfizer, focusing on oncology product strategies. An extensive educational background includes a Master's degree in Cancer Pharmacology & Toxicology from NYU, along with various research roles at prominent institutions, complemented by a certificate in Machine Learning from MIT.